Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of interfractional range variation owing to anatomical changes with beam directions based on water equivalent thickness in proton therapy for pancreatic cancer.
Kikkawa Y, Ueda H, Uchinami Y, Katoh N, Aoyama H, Ito YM, Yokokawa K, Chen Y, Matsuura T, Miyamoto N, Takao S. Kikkawa Y, et al. Among authors: takao s. J Radiat Res. 2024 Oct 8:rrae069. doi: 10.1093/jrr/rrae069. Online ahead of print. J Radiat Res. 2024. PMID: 39376078 Free article.
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity.
Uchinami Y, Katoh N, Suzuki R, Kanehira T, Tamura M, Takao S, Matsuura T, Miyamoto N, Fujita Y, Koizumi F, Taguchi H, Yasuda K, Nishioka K, Yokota I, Kobashi K, Aoyama H. Uchinami Y, et al. Among authors: takao s. Clin Transl Radiat Oncol. 2022 May 17;35:70-75. doi: 10.1016/j.ctro.2022.05.004. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35633653 Free PMC article.
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
Toramatsu C, Katoh N, Shimizu S, Nihongi H, Matsuura T, Takao S, Miyamoto N, Suzuki R, Sutherland K, Kinoshita R, Onimaru R, Ishikawa M, Umegaki K, Shirato H. Toramatsu C, et al. Among authors: takao s. Radiat Oncol. 2013 Mar 5;8:48. doi: 10.1186/1748-717X-8-48. Radiat Oncol. 2013. PMID: 23497543 Free PMC article.
Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.
Tamura M, Sakurai H, Mizumoto M, Kamizawa S, Murayama S, Yamashita H, Takao S, Suzuki R, Shirato H, Ito YM. Tamura M, et al. Among authors: takao s. J Radiat Res. 2017 May 1;58(3):363-371. doi: 10.1093/jrr/rrw088. J Radiat Res. 2017. PMID: 27789564 Free PMC article.
Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.
Hashimoto T, Shimizu S, Takao S, Terasaka S, Iguchi A, Kobayashi H, Mori T, Yoshimura T, Matsuo Y, Tamura M, Matsuura T, Ito YM, Onimaru R, Shirato H. Hashimoto T, et al. Among authors: takao s. J Radiat Res. 2019 Jul 1;60(4):527-537. doi: 10.1093/jrr/rrz022. J Radiat Res. 2019. PMID: 31111946 Free PMC article.
Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients.
Yasuda K, Minatogawa H, Dekura Y, Takao S, Tamura M, Tsushima N, Suzuki T, Kano S, Mizumachi T, Mori T, Nishioka K, Shido M, Katoh N, Taguchi H, Fujima N, Onimaru R, Yokota I, Kobashi K, Shimizu S, Homma A, Shirato H, Aoyama H. Yasuda K, et al. Among authors: takao s. J Radiat Res. 2021 Mar 10;62(2):329-337. doi: 10.1093/jrr/rraa130. J Radiat Res. 2021. PMID: 33372202 Free PMC article.
817 results